 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
| «12 |
- |||| GSK692342 / GSK, Bill & Melinda Gates Foundation
Trial completion, IO biomarker: Safety and Immunogenicity Study of a Candidate Tuberculosis Vaccine in Healthy Infants (clinicaltrials.gov) - May 9, 2012
P2, N=302, Completed, Sponsor: GlaxoSmithKline
Active, not recruiting --> Completed
- | GSK692342 / GSK, Bill & Melinda Gates Foundation
New P2 trial: Safety and Immunogenicity of a Candidate Tuberculosis (TB) Vaccine in Adults With TB Disease (clinicaltrials.gov) - Aug 25, 2011
P2, N=240, Active, not recruiting, Sponsor: GlaxoSmithKline